Emergent BioSolutions Names Frank Vargo Interim CFO Effective Jan. 1, 2027

Emergent BioSolutions CFO Richard S. Lindahl will retire effective December 31, 2026. Frank Vargo, vice president and treasurer, will become interim CFO effective January 1, 2027. Lindahl will serve as senior executive advisor from January 1 through March 31, 2027, to support the transition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001367644-26-000098), on October 16, 2026, and is solely responsible for the information contained therein. (C)